How a two-century-old medical journal became the gatekeeper of modern clinical science.
In short: Founded in 1812, The New England Journal of Medicine has evolved from a local quarterly into a global authority. While it has pioneered life-saving breakthroughs in anesthesia and oncology, the publication also faces scrutiny over its influence, editorial independence, and the occasional failure to catch flawed research before it spreads.
The New England Journal of Medicine began as a modest publication in 1812, established by Boston physicians John Collins Warren and James Jackson. It underwent several transformations, including a 1921 acquisition by the Massachusetts Medical Society, before solidifying its current identity. Today, it maintains an elite status in the medical community, consistently ranking among the highest-impact journals globally. Its reach is bolstered by a strict policy known as the Ingelfinger rule, which mandates that research must not be published elsewhere before appearing in the journal, ensuring that findings remain exclusive and undergo rigorous peer review.
Throughout its history, the journal has served as a primary venue for monumental medical advancements. It documented the first public demonstration of ether as a modern anesthetic in 1846, reported on the identification of platelets in 1906, and published early research on heart resuscitation and AIDS. In 2001, it highlighted a targeted therapy for chronic myelogenous leukemia, marking a shift toward designing drugs that address specific molecular abnormalities. These contributions have cemented its reputation as a central pillar of clinical evidence.
However, the journal’s prestige has not shielded it from controversy. Critics like Theodore Dalrymple have argued that some published conclusions lack sufficient evidentiary support. Furthermore, the journal faced significant backlash regarding its handling of Vioxx research; it was later revealed that authors of a 2000 study had withheld data on adverse events, and the journal was criticized for its slow response and financial ties to the manufacturer. Additionally, the publication has occasionally waded into political waters, such as its 2020 editorial criticizing the federal government’s management of the COVID-19 pandemic—a rare departure from its traditional focus on clinical science.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: The New England Journal of Medicine
To cite this card, link to https://intellectplus.co.uk/app/culture-the-new-england-journal-of-medicine.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Journalism and mass media · More in Cultures · Latest · A–Z · All topics
